...
首页> 外文期刊>Molecular pharmacology. >Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1
【24h】

Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1

机译:垂体腺苷酸环化酶激活多肽通过多种信号途径刺激牛肾上腺嗜铬细胞释放促胰泌素释放和促分泌素II基因转录,并​​增强预先存在的激活蛋白-1的结合

获取原文
获取原文并翻译 | 示例

摘要

Secretoneurin (SN) is a novel bioactive peptide that derives from the neuroendocrine protein secretogranin II (SgII) by proteolytic processing and participates in neuro-immune communication. The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP-38) dose-dependently stimulates (EC(50) approximately 3 nM) SN release (up to 4-fold) and SgII gene expression (up to 60-fold) in cultured bovine adrenochromaffin cells. The effect of PACAP on both SN secretion and SgII mRNA levels is rapid and long lasting. We analyzed in this neuroendocrine cell model the transduction pathways involved in both SN secretion and SgII gene transcription in response to PACAP. The cytosolic calcium chelator BAPTA-AM and the nonselective calcium channel antagonist NiCl(2) equally inhibited both secretion of the peptide and transcription of the SgII gene, indicating a major contribution of calcium influx in PACAP-induced SN biosynthesis and release in chromaffin cells. Inhibition of protein kinase A (PKA) or C (PKC) also reduced PACAP-evoked SN release but did not alter the stimulatory effect of PACAP on SgII mRNA levels. Conversely, application of mitogen-activated protein kinase inhibitors suppressed PACAP-induced SgII gene expression. The effect of PACAP on SgII mRNA levels, like the effect of the PKC stimulator 12-O-tetradecanoylphorbol-13-acetate (TPA), was not affected by cycloheximide, whereas the effects of the PKA stimulator forskolin or cell-depolarization by high K(+) were significantly reduced by the protein synthesis inhibitor. PACAP and TPA both increased the binding activity of the SgII cAMP response element to trans-acting factors present in chromaffin cell nuclear extracts, which are recognized by antibodies to activator protein-1-related proteins. These data indicate that SN biosynthesis is regulated by PACAP in chromaffin cells through complex signaling cascades, suggesting that SN may play a function during trans-synaptic stimulation of the adrenal medulla.
机译:分泌神经尿素(SN)是一种新型的生物活性肽,它通过蛋白水解过程衍生自神经内分泌蛋白secretogranin II(SgII),并参与神经免疫通讯。神经肽垂体腺苷酸环化酶激活多肽(PACAP-38)剂量依赖性地刺激(EC(50)约3 nM)SN释放(最高达4倍)和SgII基因表达(最高达60倍)在培养的牛肾上腺嗜铬蛋白中细胞。 PACAP对SN分泌和SgII mRNA水平的影响迅速而持久。我们在此神经内分泌细胞模型中分析了响应于PACAP的SN分泌和SgII基因转录的转导途径。胞质钙螯合剂BAPTA-AM和非选择性钙通道拮抗剂NiCl(2)均能抑制肽的分泌和SgII基因的转录,表明钙内流在PACAP诱导的SN生物合成中的主要贡献以及在嗜铬细胞中的释放。抑制蛋白激酶A(PKA)或C(PKC)也会减少PACAP引起的SN释放,但不会改变PACAP对SgII mRNA水平的刺激作用。相反,应用有丝分裂原活化的蛋白激酶抑制剂可抑制PACAP诱导的SgII基因表达。 PACAP对SgII mRNA水平的影响(如PKC刺激物12-O-十四烷酰phorbol-13-乙酸盐(TPA)的作用)不受环己酰亚胺的影响,而PKA刺激物福司高林或高K对细胞去极化的影响(+)被蛋白质合成抑制剂显着降低。 PACAP和TPA都增加了SgII cAMP响应元件与存在于嗜铬细胞核提取物中的反式作用因子的结合活性,所述反式作用因子被针对激活蛋白1相关蛋白的抗体所识别。这些数据表明,SNCAP的生物合成受复杂的信号级联反应在嗜铬细胞中的PACAP调控,提示SN可能在跨突触刺激肾上腺髓质的过程中发挥功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号